ClinicalTrials.gg
CompletedNCT07410299Updated Aug 27, 2026

The Perceived Point of Muscular Discomfort vs the Point of Failure in the Ageing Population- a Pilot Study

An interventional study of Resistance Exercise Protocol in Muscle Fatigue Caused by Repetitive Muscle Exercise, sponsored by Lancaster University. Completed at 1 site in United Kingdom. Open to participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Lancaster University · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Not applicable
Ages
60 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 65 studies in Fatigue with a site in United Kingdom — 13 open to participants now, 16 under way, 2 of them phase 3. Fatigue · United Kingdom.

Enrollment
44th of 47
16 · median 60
Started
2026
with 7 others
No phase
35 of 65
7 open now
Registered
58th of 65
by date
Lead sponsor
5 of 65
Lancaster University

Among the 65 studies in Fatigue with a site in United Kingdom, this one is the 44th largest by enrollment of the 47 interventional ones that give a count, is one of 8 that started in 2026, is one of 35 with no phase, and was the 58th registered.

Fatigue

2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.

Browse Fatigue studies →

Open to participants now

13 of the 65 studies in Fatigue with a site in United Kingdom are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.

This study: 60 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 65 studies in Fatigue with a site in United Kingdom, or all of them as a file.
02

Study summary

This is an investigation into the differences in muscle activation and numerical difference in reps between the feeling of moderate discomfort and technical failure during a set of bodyweight resistance exercise.

The investigators know that resistance training is an essential tool for older people to maintain muscle function, valuable independence and autonomy in daily tasks. The idea of completing a set of resistance training activity to the point of failing a repetition due to fatigue regularly has been shown to not be appealing and could be a reason why there are low participation rates among older people for in weight training regularly.

Research has also shown that it is not necessary to train to failure (being unable to continue to complete repetitions of an exercise with the proper technique due to fatigue), but the investigators would like to know if training to a point of moderate discomfort can also allow for the muscles to gain the positive changes associated with weight training, potentially making it more accessible and enjoyable.

Using bodyweight exercises (a squat pattern and a push up pattern) the investigators will see how many repetitions after the point of perceived moderate discomfort is stated at which the point of failure is. the investigators will also measure muscle activation in the quadriceps and triceps with EMG (a device that can detect the muscles' electrical activity/ how hard it is working) to see at which point the muscle is working the hardest.

Read the detailed description

Before participation, the participant will undergo a health screening that follows the standard operating procedures of the Human Performance Laboratory. This involves measurements of height, weight, body fat percentage, blood glucose, blood pressure and heart rhythm abnormalities. Blood glucose will be measured using capillary blood via a finger prick test administered by the principal investigator. A very small amount of blood will be drawn into a capillary tube and then analysed in a machine (Biosen) to quantify the levels of blood glucose/sugar in the sample. Heart abnormalities will be measured using a device that is non-invasive and just requires the participant to place their fingers on a pad for one minute. The body fat percentage te69st is also non-invasive, requiring the participants to stand on a scale (Tanita body scanner) with their shoes and socks off.

EMG electrodes will then be placed on the triceps and quadriceps after standard skin preparation has taken place. After this the participant will complete a standardised isometric maximal voluntary contraction so the EMG activity can be standardised as % maximal voluntary contraction (%MVC). The details of the MVC protocol can be found in Appendix 2.

First the participant will be led through a standardized warm up that includes the use of elastic band exercises and joint mobility work for five minutes as seen in Appendix 3.

The participant will be shown the technique of three variations of the two exercises using a mobile phone app video; beginner, intermediate and advanced variations. They will then be asked to choose which version of the exercise they think can achieve 8-15 repetitions with.

All participants will then start with the beginner variation of the squat pattern exercise. If they are able to perform each exercise for more than 20 repetitions to technical failure they will be asked to perform the intermediate variation intermediate. If they are able to perform more than 20 repetitions to technical failure they will be asked to perform the advanced version.

This process will then be repeated for the push-up pattern, of which there are also three variations, beginner, intermediate and advanced. To minimise fatigue between sets in those that are able to perform the intermediate or advanced exercises, lower and upper body exercises will be alternated and separated by 5 minutes of rest.

Before each set they will be instructed to say the word "now" during the set when they begin to feel moderate muscle discomfort, (a 5 on a scale of 1-10), see appendix 3. (Fisher et al., 2017). and the scale is described to the participant as follows: "The scale begins at 0, which is described as no perceived discomfort. This can be likened to a perception of discomfort at a time where participant felt no noticeable sensations relating to physical activity. The scale ends at 10, which is described as the maximum perceivable discomfort. This can be likened to a perception of discomfort where the participant could not imagine the sensations relating to physical activity being any more intense."

They will then be instructed to continue this set until they can no longer complete a repetition with the correct demonstrated form (technical failure). For each of the exercises the number of repetitions between the point of muscular discomfort and failure will be calculated and correlated with %MVC.

03

Conditions studied

  • Muscle Fatigue Caused by Repetitive Muscle Exercise

Browse trials for

Keywords

  • fatigue
  • Ageing population
  • resistance exercise
  • electromyography
04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 60-80 years of age.
  • Physically capable of resistance training.
  • Able to walk unassisted.

Exclusion criteria

Exclusion Criteria:

  • Major cardiovascular (e.g. myocardial infarction, angioplasty within the last year, coronary artery bypass graft), neurological (e.g. Parkinson's disease, Alzheimer's, major anxiety or depressive disorders), muscular (e.g., muscular dystrophies, myopathies, myositis) or uncontrolled metabolic conditions (e.g. Type 1 or 2 diabetes).
  • Severe obesity ( >39).
  • Have undertaken regular resistance exercise in the last 12 months.
  • Any upper or lower body musculoskeletal injury that impairs the participants ability to perform a repetition as fast as possible.
  • Acute or terminal illnesses (e.g. severe locals or systemic infections, cancer).
  • Current residence being within a setting of care.
  • Experience of muscle pain from taking statins.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    Bodyweight push-up and squat variations

    The participant will select a variation of the push-up and squat. This will either be beginner, intermediate or advanced. Muscle activity in the triceps and quadriceps muscle groups will be measured for the push-up and squat patterns respectively.

    Other: Resistance Exercise Protocol

Interventions

  • OtherResistance Exercise Protocol

    The intervention involves performing progressive variations of squat and push-up patterns to technical failure while monitored by EMG electrodes on the triceps and quadriceps. Participants verbally signal a "moderate" discomfort threshold (5/10) during each set to identify the repetition gap between perceived strain and actual physical exhaustion. This structured exercise task serves to calibrate subjective effort against objective muscle activation (%MVC) to map the physiological mechanics of fatigue.

06

What researchers measure

Primary outcomes

  1. The number of reps between reported perceived moderate muscular discomfort and technical failure.

    The quantitative difference between the rep number that the participant reports the feeling of moderate muscular discomfort at (5 on a scale of 1-10) compared to the rep number that technical failure of the set occurs.

    Time frame: During 1 set of body weight resistance exercise.

Secondary outcomes

  1. Muscle Activity

    Electromyography amplitude of the quadriceps and triceps muscle groups to measure muscle activation.

    Time frame: During intervention

  2. Accuracy of exercise difficulty selection

    The ability of the participant to accurately select an appropriate exercise difficulty that allows them to complete between 8 and 15 repetitions. This will be collected as "yes" or "no" by the investigator for each participant based on their ability to complete what they perceive to be the correct difficulty of exercise variation. If the participant was able to select an appropriate difficulty of variation the investigator will record "yes", if they are not able to select an appropriate variation then the investigator will record "no".

    Time frame: Immediately after intervention

07

Study locations

1 site
  • Lancaster University
    Lancaster, Lancashire LA1 4YW, United Kingdom
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2026 to primary completion in May 2026, 3 months.

Of 937 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's 3 months is below that.

Counting every sponsor, half of 990 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2026
First posted
Feb 13, 2026
StartActual
Feb 10, 2026
Primary completionActual
May 10, 2026
CompletionActual
May 10, 2026
Last update
Aug 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07410299
Lead sponsor
Lancaster University
Responsible party
Matthew Davitt (PhD Student, Lancaster University) — Principal investigator
First posted
Feb 13, 2026
Start date
Feb 10, 2026
Primary completion
May 10, 2026
Completion
May 10, 2026
Last update
Aug 27, 2026

Study contacts

Paul Hendrickse, PhD
principal investigator · Lancaster University
Lawrence Hayes, PhD
principal investigator · Lancaster University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion